Immunomodulatory therapies in community-acquired pneumonia: a protocol for a systematic review and network meta-analysis
Introduction Community-acquired pneumonia is the leading global cause of infection-related death. A subset of patients with pneumonia develops aberrant immune responses, resulting in harmful inflammation, tissue damage and significant mortality. Immunomodulatory therapies aim to blunt this dysregula...
Saved in:
| Main Authors: | Dominique-Laurent Couturier, Luke Flower, Charlotte Summers, Joseph Newman, Martin Law |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/7/e098994.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effectiveness of Immunomodulatory Therapy of Community-acquired Pneumonia in Frequently ill Children
by: T. G. Malanicheva, et al.
Published: (2018-12-01) -
Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01) -
Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
by: O. V. Molchanova, et al.
Published: (2020-05-01) -
Importance of Streptococcus pneumoniae in Community-Acquired Pneumonia
by: Thomas J Marrie
Published: (1999-01-01) -
Pharmacogenetics of Community-Acquired Pneumonia
by: S. SH. Suleimanov, et al.
Published: (2020-05-01)